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Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat mood and anxiety disorders.
However, neuronal bases for both beneficial and adverse effects of SSRIs remain poorly understood. We have
recently shown that the SSRI fluoxetine can reverse the state of maturation of hippocampal granule cells in adult
mice. The granule cell “dematuration” is induced in a large population of granule cells, and greatly changes
functional and physiological properties of these cells. Here we show that this unique form of neuronal plasticity is
correlated with a distinct change in behavior of mice.
Results: We chronically treated adult male mice with fluoxetine, and examined its effect on several forms of
behavior of mice. During fluoxetine treatments, mice showed a marked increase in day-to-day fluctuations of home
cage activity levels that was characterized by occasional switching between hypoactivity and hyperactivity within a
few days. This destabilized cage activity was accompanied by increased anxiety-related behaviors and could be
observed up to 4 weeks after withdrawal from fluoxetine. As reported previously, the granule cell dematuration by
fluoxetine includes a reduction of synaptic facilitation at the granule cell output, mossy fiber, synapse to the
juvenile level. Mossy fiber synaptic facilitation examined electrophysiologically in acute hippocampal slices also
remained suppressed after fluoxetine withdrawal and significantly correlated with the fluctuation of cage activity
levels in individual mice. Furthermore, in mice lacking the 5-HT4 receptor, in which the granule cell dematuration
has been shown to be attenuated, fluoxetine had no significant effect on the fluctuation of cage activity levels.
Conclusions: Our results demonstrate that the SSRI fluoxetine can induce marked day-to-day changes in activity
levels of mice in the familiar environment, and that the dematuration of the hippocampal granule cells is closely
associated with the expression of this destabilized behavior. Based on these results, we propose that the granule
cell dematuration can be a potential cellular basis underlying switching-like changes in the behavioral state
associated with SSRI treatments.
Background
Selective serotonin reuptake inhibitors (SSRIs) have
been commonly used to treat mood and anxiety disor-
ders, while some severe adverse effects have been
reported [1,2]. Although SSRIs can immediately change
extracellular levels of serotonin in the central nervous
system, therapeutic effects of these drugs usually require
weeks of treatments [3]. Some of adverse psychiatric
effects of SSRIs also emerge with a delayed onset during
chronic treatments or even after withdrawal of the
drugs [4,5]. Thus, adaptive or plastic changes in the cen-
tral nervous system are likely to be involved in adverse
effects as well as therapeutic effects of SSRIs. In experi-
mental animals, SSRIs and other antidepressant drugs
can generally facilitate adult neurogenesis in the dentate
gyrus of the hippocampus, and this process has been
suggested to underlie some of behavioral effects of these
drugs [6-8]. The facilitatory effect on the adult neuro-
genesis usually requires a few weeks of administration,
which could explain the delayed manifestation of the
effects of the drugs at the behavioral level. However, it
remains unknown how the facilitated neurogenesis leads
to modifications of hippocampal functioning that can
cause robust changes in behavior. We have recently
shown that chronic treatments with fluoxetine, a widely
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used SSRI, can reverse the established state of matura-
tion of the dentate granule cell in adult mice [9]. The
change in the state of the granule cell maturation gradu-
ally develops over the course of the fluoxetine treatment
for a few weeks and is manifested as marked changes in
physiological and functional properties of the granule
cell that include neuronal excitability, activity-dependent
synaptic modifications, and immediate early gene
expression [9]. Since this novel form of neuronal plasti-
city is induced in a large population of the dentate gran-
ule cells, it is supposed to have a substantial impact on
the operation of hippocampal neuronal circuits and
probably on hippocampus-dependent regulation of
behaviors. In the present study, we analyzed changes in
behaviors of mice treated with fluoxetine in a regimen
that is sufficient for the induction of granule cell dema-
turation, and examined the association between
observed behavioral changes and the granule cell
dematuration.
Results
Destabilization of home cage activity by chronic
fluoxetine
Fluoxetine was applied for 4 weeks at a dose of 14 or 22
mg/kg/day. Our previous study showed that fluoxetine
induces dematuration of the dentate granule cells at 22
mg/kg/day, but not at 14 mg/kg/day [9]. In order to
assess a behavioral correlate of the granule cell dema-
turation, we analyzed effects of both doses of fluoxetine
on several forms of behaviors of mice. First, activity
levels of mice in their home cages were continuously
monitored during the treatment (Figure 1A-1F). In
some of these mice, electrophysiological recordings were
also performed after monitoring cage activity to assess
the state of the granule cell maturation (Figure 1A, 1C
and 1E). In control mice, the home cage activity levels
were quite stable throughout the course of experiments
(Figure 1A left) except for a gradual small decline as
seen in the averaged data (Figure 1B). After starting
administration of fluoxetine at 14 mg/kg/day (FLX14),
the activity level of mice was initially decreased, but
remained stable thereafter (Figure 1C left and 1D). In
contrast, fluoxetine at 22 mg/kg/day (FLX22) caused a
distinct change in the home cage activity. Mice treated
with FLX22 also exhibited an initial decrease in activity
levels (Figure 1E left and 1F). In about 2 weeks of treat-
ments, however, they started showing a marked day-to-
day fluctuation of activity levels (Figure 1E left) that was
accompanied by occasional switching from hypoactivity
to hyperactivity and vice versa in a few days (see also
Figure 2A). To quantify this fluctuation of home cage
activity, we calculated the coefficient of variation (CV)
of activity levels during the last 2 weeks of the treat-
ments. There was a highly significant difference in CV
between FLX22 and other groups (Figure 1G). The
mean activity level during the same period tended to be
higher in FLX22-treated mice (see Figure 1B, 1D and
1F), but there was no statistically significant difference
between groups (p > 0.05, rank sum difference = 4.327
for control vs. FLX22, 12.2 for control vs. FLX14, and
16.53 for FLX14 vs. FLX22).
The granule cell dematuration induced by FLX22
includes reversal of functional maturation of these cells
[9]. In the matured state, the synapse between the
mossy fiber, the granule cell axon, and CA3 pyramidal
cells shows prominent frequency facilitation (see Figure
1A right), and this frequency facilitation is greatly
reduced in the immature or dematurated granule cells
[9-11]. To directly investigate the relationship between
this physiological index of granule cell dematuration
and the behavioral change, we made electrophysiological
recordings using hippocampal slices prepared from mice
whose home cage activity had been monitored. In con-
trol and FLX14-treated mice, strong frequency facilita-
tion was induced at the mossy fiber synapse by 1 Hz
stimulation (Figure 1A right and 1C right). In FLX22-
treated mice that showed marked fluctuation of cage
activity levels, frequency facilitation was strongly
decreased (Figure 1E right), confirming the induction of
the granule cell dematuration in these mice. The magni-
tude of mossy fiber synaptic facilitation in FLX22-trea-
ted mice was negatively correlated with CV of home
cage activity levels in individual mice (Figure 1H). Thus,
mice with more dematurated mossy fiber synapses
exhibited larger changes in fluctuation of activity.
In some cases, we stopped administration of fluoxetine
while continuously monitoring the home cage activity
(Figure 2A). Although the results were variable, the activ-
ity fluctuation could be clearly observed at least up to 4
weeks after discontinuation of the fluoxetine treatment,
and one mouse showed marked fluctuation only after the
discontinuation (Figure 2A and 2B). Thus, the destabili-
zation of home cage activity by FLX22 cannot be simply
explained by fluctuation of acute actions or tissue con-
centrations of fluoxetine, but is likely caused by some
plastic changes in the central nervous system. We also
examined the mossy fiber synaptic transmission in mice
withdrawn from FLX22, and found that frequency facili-
tation remained suppressed 4 weeks after the withdrawal
(Figure 2C), suggesting that the granule cells were still in
the dematurated state. Taken together, these results indi-
cate that the granule cell dematuration is associated with
destabilization of home cage activity of mice.
Increased anxiety-related behaviors caused by chronic
fluoxetine
We further characterized behavioral changes caused by the
fluoxetine treatments. FLX14 slightly reduced horizontal
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activity of mice in the open-field test (Figure 3A) and
light/dark transition test (Figure 3B), but had no signifi-
cant effects on indexes of anxiety-related behaviors in
these tests (Figure 3A and 3B) and the elevated plus-maze
test (Figure 3C). These results are similar to our previous
report of behaviors of mice treated with fluoxetine at
10 mg/kg/day [12]. Effects of FLX22 on behaviors in these
tests were completely different from those of FLX14.
FLX22 had no suppressive effects on the locomotor activ-
ity in the open-field test (Figure 4A) and light/dark transi-
tion test (Figure 4B), induced hyperactivity in the elevated
plus-maze test (Figure 4C), and consistently increased
Figure 1 Fluoxetine destabilizes home cage activity. (A) Representative data showing nocturnal locomotor activity levels in home cage (left)
and frequency facilitation at the mossy fiber synapse induced by 1 Hz stimulation (right) in a control (CNT) mouse. (B) Averaged data of
nocturnal activity levels in control mice. (C) Representative nocturnal activity and synaptic facilitation, and (D) averaged nocturnal activity in mice
treated with 14 mg/kg/day fluoxetine (FLX14). (E) Representative nocturnal activity and synaptic facilitation, and (F) averaged nocturnal activity in
mice treated with 22 mg/kg/day fluoxetine (FLX22). Representative behavioral and electrophysiological data were obtained from the same mice.
Averaged data are presented as mean ± s.e.m. (G) Coefficient of variation (CV) of activity levels during last 2 weeks of treatments. FLX22 (n = 29)
mice showed larger variation than control (n = 27, rank sum difference = 29.48, p < 0.0001) and FLX14 (n = 9, rank sum difference = 27.11, p <
0.0001). There was no significant difference between control and FLX14 (rank sum difference = 2.37, p > 0.05). (H) CV of activity was negatively
correlated with the magnitude of frequency facilitation at the mossy fiber synapse in FLX22 mice (n = 16, p = 0.0007, r2 = 0.569). Each symbol
represents a single mouse.
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anxiety-related behaviors: FLX22 reduced time spent in
the center of the open field (Figure 4A), time spent in the
light box (Figure 4B), and relative entry into open arms
(Figure 4C). On the other hand, FLX14 and FLX22 had
similar effects on depression-related behaviors. Immobile
time was increased in the forced swim test, but decreased
in the tail suspension test in both conditions (Figure 5A
and 5B). Taken together, these results suggest that the
granule cell dematuration induced by FLX22 is associated
with increased anxiety-related behaviors as well, but not
with the depression-related behaviors assessed in the pre-
sent study.
Requirement of serotonin 5-HT4 receptor for behavioral
effects of fluoxetine
We have previously shown that the granule cell dema-
turation is attenuated in mice lacking the serotonin 5-
HT4 receptor [9]. To further investigate the association
between the granule cell dematuration and behavioral
effects of fluoxetine, we carried out the same battery of
behavioral tests in 5-HT4 receptor-deficient (5-HT4-/-)
mice with the genetic background of C57BL/6J. As in
normal C57BL/6J mice, FLX22 induced destabilization
of home cage activity in the wild-type (5-HT4+/+) mice
(Figure 6A and 6B). In 5-HT4-/- mice, however, FLX22
reduced mean activity levels in home cages with no sig-
nificant effect on CV of activity (Figure 6C and 6D).
Effects of FLX22 on other forms of behaviors in 5-HT4
Figure 2 Home cage activity and synaptic transmission after
discontinuation of fluoxetine administration. (A) Sample data
showing effects of FLX22 administration and withdrawal on
nocturnal activity in two different mice. (B) CV of activity during
FLX22 treatments and after discontinuation of the treatments. Data
points connected by lines were from the same mice. (C) Pooled
data showing reduced 1 Hz frequency facilitation at the mossy fiber
synapse 4 weeks after discontinuation of fluoxetine treatments (n =
6 each, U = 0, p = 0.0022). The dotted line shows the average level
of facilitation in mice treated with FLX22 for 4 to 5 weeks without
discontinuation. Sample recordings are averages of 15 consecutive
fEPSPs before and during 1 Hz stimulation. Scale bar: 10 ms, 0.5 mV.
Data are presented as mean ± s.e.m.
Figure 3 Effects of FLX14 on locomotor activity and anxiety-
related behavior. (A) FLX14 reduced the total distance traveled in
the open-field test (z = 2.094, p = 0.0363), but had no significant
effect on time spent in the center of the field (z = 0.952, p =
0.3412, CNT: n = 13, FLX14: n = 12). Time in center is indicated as
percent time spent in the center relative to the total time in the
field. (B) FLX14 reduced the total distance traveled in the light/dark
transition test (z = 2.203, p = 0.0276), but had no significant effects
on the number of transition between two compartments (z = 0.952,
p = 0.3408), time spent in the light box (z = 0.408, p = 0.6833), or
latency to enter the light box (z = 1.822, p = 0.0685, CNT: n = 13,
FLX14: n = 12). Time in light is indicated as percent time spent in
the light compartment relative to the total test time. (C) In the
elevated plus-maze test, FLX14 had no significant effects on the
total distance traveled (z = 0.68, p = 0.4966), the total number of
entries into arms (z = 0.897, p = 0.3693), time spent on open arms
(z = 1.523, p = 0.1278), or entry into open arms (z = 1.768, p =
0.0772, CNT: n = 13, FLX14: n = 12). Time in open arms and open
arm entry are indicated as percent time spent on open arms
relative to the total test time and the percent number of entries
into open arms relative to the total number of entries, respectively.
Data are presented as mean ± s.e.m.
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+/+ mice were also generally comparable to those in
normal C57BL/6J mice: FLX22 increased anxiety-related
behaviors in the open field and light/dark transition
tests (Figure 7A and 7B), and increased immobile time
in the forced swim test (Figure 7D). However, FLX22
did not significantly change the behaviors of 5-HT4+/+
mice in the elevated plus-maze test (Figure 7C) and tail
suspension test (Figure 7D), and induced exaggerated
anxiety-like responses in the light/dark transition test
(Figure 7B). In 5-HT4-/- mice, FLX22 had no significant
effects on behaviors in the open-field, light/dark transi-
tion and elevated plus-maze tests (Figure 8A, 8B and
8C). However, effects of FLX22 in the forced swim and
tail suspension tests were similar to those in 5-HT4+/+
and normal C57BL/6J mice (Figure 8D), excluding the
possibility that the 5-HT4 deficiency nonspecifically sup-
pressed fluoxetine actions. These results further support
the idea that the granule cell dematuration is associated
with destabilization of home cage activity and increased
anxiety-related behaviors, but not with the depression-
related behaviors.
Discussion
The present study demonstrated that chronic fluoxetine
treatments induced a marked day-to-day fluctuation of
activity levels of mice in familiar environments. This
novel behavioral effect of fluoxetine was strongly asso-
ciated with the dematuration of dentate granule cells
induced by fluoxetine [9]: 1) Both effects were observed
at 22 mg/kg/day, but not at 14 mg/kg/day, 2) both
effects started emerging in about 2 weeks of the treat-
ment [9], 3) both effects were suppressed in 5-HT4
receptor-deficient mice, and 4) the fluctuation of activity
levels was negatively correlated with the magnitude of
frequency facilitation at the mossy fiber-CA3 synapse,
the physiological index of the state of granule cell
maturation [9-11,13]. In mice heterozygous for alpha-
Figure 4 Effects of FLX22 on locomotor activity and anxiety-
related behavior. (A) FLX22 reduced time spent in the center of
the open field (z = 4.766, p < 0.0001), but had no significant effect
on the total distance traveled (z = 0.08, p = 0.9361, CNT: n = 25,
FLX22: n = 28). (B) FLX22 reduced time spent in the light
compartment in the light/dark transition test (z = 3.185, p = 0.0015)
and increased the latency to enter the light compartment (z =
2.217, p = 0.0267), but had no significant effects on the total
distance traveled (z = 0.176, p = 0.8602) or the number of transition
between two compartments (z = 0.983, p = 0.3253, CNT: n = 17,
FLX22: n = 21). Two fluoxetine-treated mice did not enter the light
compartment. (C) FLX22 increased the total distance traveled (z =
2.69, p = 0.0072) and the number of entries into arms (z = 2.465, p
= 0.0137), and decreased relative entry into open arms (z = 2.704, p
= 0.0069), but had no significant effect on time in open arms (z =
1.225, p = 0.2205) in the elevated plus-maze test (CNT: n = 18,
FLX22: n = 21). Percent values are calculated as in Figure 3.
Figure 5 Effects of fluoxetine on depression-related behavior.
(A) FLX14 increased immobile time in forced swim test (CNT: n =
13, FLX14: n = 12, z = 3.726, p = 0.0002) and decreased immobile
time in tail suspension test (CNT: n = 7, FLX14: n = 8, U = 8, p =
0.0205). (B) FLX22 increased immobile time in forced swim test
(CNT: n = 16, FLX22: n = 18, z = 3.088, p = 0.0009) and decreased
immobile time in tail suspension test (CNT: n = 7, FLX22: n = 8, U =
8, p = 0.0205). Immobile time is indicated as percent time spent
immobile relative to the total time monitored.
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calcium/calmodulin-dependent protein kinase II (alpha-
CaMKII+/- mice), the dentate granule cells stay in the
immature state even in adults, and these mice also show
strongly reduced frequency facilitation at the mossy
fiber synapse and aberrant home cage behaviors with
large periodic changes in activity levels [11]. These lines
of evidence raise the possibility that the abnormality in
the state of granule cell maturation causes instability in
activity of mice in familiar environments. Since lesion of
the hippocampus consistently causes hyperactivity in
home cages [14-16], the hippocampus certainly plays an
essential role in regulating activity levels in familiar
environments. The dematurated granule cells in the
fluoxetine-treated mice and immature granule cells in
alpha-CaMKII+/- mice exhibit similar and characteristic
changes in their functional properties [9,11]. Higher
excitability in these granule cells would allow propaga-
tion of more cortical excitation into the hippocampus,
and the reduced mossy fiber synaptic facilitation would
impair the instructive role of the mossy fiber input in
the induction of associative synaptic plasticity in the
CA3 region [17,18]. In addition, activity-dependent
expression of the immediate early gene c-fos is nearly
completely suppressed in both dematurated and imma-
ture granule cells in these mice [9,11]. These diverse
changes in granule cell functioning would substantially
modify activity of the hippocampal neuronal circuit [13],
thereby quite likely affecting hippocampus-dependent
behaviors such as locomotor activity in home cages. It
should be noted that immaturity or dematuration of the
dentate granule cells can be assessed not only by the
electrophysiological method, but also by a real-time
PCR or histochemical analysis of expression of molecu-
lar markers such as calbindin and tryptophan 2,3-dioxy-
genase [9,11,19-21]. These molecular markers would be
useful in examining a possible association between
abnormality in the state of granule cell maturation and
behavioral phenotypes in other mutant or drug-treated
mice. The aberrant behavioral effect of fluoxetine
observed here might be related to adverse effects of
fluoxetine and other SSRIs in humans. SSRIs can induce
switching to mania or mood destabilization, especially in
patients with bipolar disorder [1,5], and the switching to
mania can be observed even after discontinuation of
SSRI medication [4]. Since the destabilization of mouse
behaviors were observed at the dose higher than the
clinical therapeutic dose of fluoxetine and suggested
optimal dose for mice [22], this effect may not be
directly relevant to clinical symptoms or behavioral
changes in humans. Although further studies are neces-
sary to clarify the clinical relevance of the present result,
our finding indicates that the SSRI fluoxetine has the
Figure 6 Suppression of fluoxetine-induced behavioral destabilization in 5-HT4-deficient mice. (A) Averaged data showing home cage
activity levels of control and FLX22-treated 5-HT4+/+ mice (n = 9 each). (B) FLX22 increased CV of activity levels during last 2 weeks of
treatments in 5-HT4+/+ mice (U = 5, p = 0.0008), but had no significant effect on mean activity levels during the same period (U = 30, p =
0.3865). (C) Averaged data showing home cage activity levels of control and FLX22-treated 5-HT4-/- mice (n = 11 each). (D) FLX22 reduced mean
activity levels during last 2 weeks of treatments (z = 2.627, p = 0.0087), but had no significant effect on CV of activity in 5-HT4-/- mice (z = 0.591,
p = 0.5546).
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potential to induce rapid changes in the behavioral state
during chronic treatments and after discontinuation of
the treatments.
The granule cell dematuration was associated with the
increased anxiety-related behaviors in addition to the
behavioral destabilization. Some previous studies have
also shown that chronic fluoxetine can increase anxiety-
related behaviors [23,24]. In our studies using adult
mice, the anxiogenic-like effect of fluoxetine was
observed at 22 mg/kg/day, but not at 14 mg/kg/day or
10 mg/kg/day [12]. On the other hand, Oh et al. (2009)
have shown the anxiogenic-like effect of fluoxetine at as
low as 3 mg/kg/day in juvenile mice [24]. In their study,
fluoxetine was administered from the age of 2 through 6
weeks. The magnitude of frequency facilitation at the
mossy fiber synapse reaches the mature level at the age
of 3 or 4 weeks in mice [9,10]. Therefore, at the begin-
ning of such treatment period, many granule cells are
supposed to be in the immature state. It is possible that
the difference in the state of maturation of granule cells
contributes to the higher potency of fluoxetine in
increasing anxiety-related behaviors in young mice.
While the present study shows the association between
the granule cell dematuration and increased anxiety-
related behaviors, alpha-CaMKII+/- mice, which have
immature granule cells, exhibit greatly reduced anxiety-
related behaviors [11]. This apparent discrepancy could
be due to differences in neuronal functions in brain
regions other than the dentate gyrus. Alternatively, it
might be ascribed to differences in physiological proper-
ties between the fluoxetine-treated dematurated granule
cells and the immature granule cells in alpha-CaMKII
+/- mice. The immature granule cells in alpha-CaMKII
+/- mice are more easily excited by depolarizing current
injection than the fluoxetine-treated dematurated gran-
ule cells, but show a faster decline of firing during pro-
longed depolarization [9,11]. Therefore, these two types
of granule cells could behave in a quite different way in
some occasions, thereby differentially contributing to
the same hippocampus-dependent behavior.
Our results demonstrated the involvement of the
5-HT4 receptor in some of behavioral effects of fluoxe-
tine. This finding is in line with the previous report
showing that subchronic administration of 5-HT4
Figure 7 Effects of fluoxetine on anxiety- and depression-related behaviors in wild-type littermates of 5-HT4-deficient mice. (A) FLX22
reduced time spent in the center of the open field (U = 3, p = 0.0003), but had no significant effect on the total distance traveled (U = 28, p =
0.3154) in 5-HT4+/+ mice (CNT: n = 10, FLX22: n = 8). (B) FLX22 reduced the total distance traveled (U = 15, p = 0.0464), the number of
transition (U = 2.5, p = 0.0003), and time spent in the light compartment (U = 0, p < 0.0001) and increased the latency to enter the light
compartment (U = 6, p = 0.0025) in the light/dark transition test in 5-HT4+/+ mice (CNT: n = 9, FLX22: n = 8). Four fluoxetine-treated mice did
not enter the light compartment. (C) FLX22 had no significant effects on the total distance traveled (U = 36, p = 0.7618), the total number of
entries into arms (U = 31, p = 0.4598), time spent on open arms (z = 0.8, p = 0.4082), or entry into open arms (U = 20, p = 0.0831) in elevated
plus-maze test in 5-HT4+/+ mice (CNT: n = 10, FLX22: n = 8). (D) FLX22 increased immobile time in forced swim test in 5-HT4+/+ mice (CNT: n =
10, FLX22: n = 8, U = 11, p = 0.0085), but had no significant effect in the tail suspension test (U = 19, p = 0.0676). Percent values are calculated
as in Figure 3 and 5.
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receptor partial agonists had antidepressant-like beha-
vioral effects in rats [25]. The 5-HT4 receptor is abun-
dantly expressed in the dentate granule cells [26],
mediates serotonin-induced synaptic potentiation at the
mossy fiber synapse [9,12], and is essential for the gran-
ule cell dematuration induced by FLX22 [9]. In
5-HT4-/- mice, FLX22 had no significant effects on fluc-
tuation of home cage activity levels or anxiety-related
behaviors. Since we did not observe any obvious differ-
ence in behaviors between the 5-HT4+/+ and 5-HT4-/-
mice of the fluoxetine-free control groups, it is unlikely
that behavioral effects of fluoxetine were masked by pre-
existing behavioral abnormalities in the mutant mice. In
addition, FLX22 was still effective in changing some
forms of behaviors in 5-HT4-/- mice: FLX22 changed
the depression-related behaviors as in 5-HT4+/+ and
normal C57BL/6J mice and significantly reduced activity
levels in the home cages instead of inducing destabiliza-
tion of activity. Thus, the 5-HT4 deficiency does not
have nonselective suppressing effects on fluoxetine
actions, supporting the specific association between
fluoxetine-induced behavioral and cellular changes that
are attenuated in the mutant mice. Compan et al. (2004)
have reported a significant decrease in open-field loco-
motor activity in 5-HT4-/- mice [27]. This discrepancy
may be due to differences in experimental conditions,
most probably the difference in the genetic background
of the mutant mice: 129/Sv in Compan et al. (2004) vs.
C57BL/6J in our study.
Conclusions
Chronic fluoxetine treatments can induce destabilization
of home cage behaviors in normal mice that is character-
ized by occasional switching between hyperactivity and
hypoactivity within a few days. This behavioral destabili-
zation was attenuated in mice lacking the serotonin 5-
HT4 receptor and tightly associated with the fluoxetine-
induced dematuration of the dentate granule cells. Based
on these results, we propose that the dematuration of
dentate granule cells can be a candidate cellular process
underlying switching-like changes in the behavioral state
that are associated with SSRI treatments.
Figure 8 Effects of fluoxetine on anxiety- and depression-related behaviors in 5-HT4-deficient mice. (A) FLX22 had no significant effects
on the total distance traveled (U = 23, p = 0.3823) or time spent in the center (U = 22, p = 0.3282) in the open field test in 5-HT4-/- mice (n =
8 each). (B) FLX22 had no significant effects on the total distance traveled (U = 30, p = 0.8785), the number of transition (z = 1.05, p = 0.2786),
time spent in the light compartment (z = 0.735, p = 0.4418), or the latency to enter the light compartment (U = 31, p = 0.9591) in the light/dark
transition test in 5-HT4-/- mice (n = 8 each). (C) FLX22 had no significant effects on the total distance traveled (U = 28, p = 0.7209), the total
number of entries into arms (z = 0.945, p = 0.3282), time spent on open arms (U = 32, p = 1), or entry into open arms (U = 28, p = 0.7209) in
the elevated plus-maze test in 5-HT4-/- mice (n = 8 each). (D) FLX22 increased immobile time in the forced swim test (n = 8 each, U = 4, p =
0.0019) and decreased immobile time in the tail suspension test in 5-HT4-/- mice (n = 8 each, U = 7, p = 0.007). Percent values are calculated as
in Figure 3 and 5.
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Methods
Drug Treatment
Male C57BL/6J mice were singly housed from the age of
8 weeks in the institutional standard condition (14:10
light/dark cycle; lights on at 6:00 A.M. through 8:00 P.
M.) at 23 ± 1°C with food and water available ad libi-
tum. Following 1 week of acclimation, fluoxetine hydro-
chloride (Wako Pure Chemical Industries, Ltd., Osaka,
Japan) was orally applied at a dose of 14 or 22 mg/kg/
day. In order to minimize stress associated with drug
administration, fluoxetine was dissolved in the drinking
water. The fluoxetine solutions were prepared everyday,
and concentrations of fluoxetine were determined for
individual mice based on the water consumption during
preceding 24 h and the body weight measured every
other day [9]. Saccharin (0.2%) was included in the
fluoxetine solution to keep water intake comparable to
the baseline [9]. Control mice were given water with or
without saccharin, and all data were pooled. After
4 weeks of fluoxetine treatments, behavioral tests were
started, and fluoxetine treatments were continued dur-
ing the tests. The 5-HT4 receptor heterozygous mutant
mice (strain name: B6.129P2-Htr4 < tm1Dgen >/J) were
purchased from the Jackson Laboratory (Bar Harbor,
ME, USA). These mice had been backcrossed to the
C57BL/6J background for 10 generations. Male wild-
type (5-HT4+/+) and homozygous mutant (5-HT4-/-) lit-
termates from heterozygous mating were treated with
fluoxetine and used for experiments. There was no sig-
nificant difference in the actual doses of fluoxetine
administered to mice between the genotypes. All proce-
dures were approved by the institutional Animal Care
and Use Committee.
Home cage activity monitoring
Mice were singly housed in the cage (15 × 25 × 30 cm)
equipped with an infrared video camera at the top, and
locomotor (horizontal) activity in the cage was continu-
ously monitored. Outputs from the cameras were fed
into a personal computer. Images were captured at a
rate of one frame per second, and the distance traveled
per minute was analyzed online using software based on
the public domain ImageJ (ImageJ HC8; O’Hara and
Co., Ltd., Tokyo, Japan). Since activity of mice during
the light period could be affected by external stimuli
such as noise made by workers in the animal facility,
the activity during the dark period (nocturnal activity)
was evaluated in quantitative analyses.
Behavioral experiments
Mice were transferred to a behavioral testing room and
allowed to acclimatize to the environment of the room
for at least 1 h 30 min before starting behavioral tests.
All tests were performed between 13:30 P.M. and 18:00
P.M. The tests were sequentially performed on different
days in the order of the open-field test, light-dark transi-
tion test, elevated plus-maze test, forced swim test and
tail suspension test. Only one test was conducted for
each mouse in a day. Room temperature was kept at 24
± 0.5 °C. To minimize olfactory cues from the previous
trial, each apparatus was wiped and cleaned with a
hypochlorous acid solution (~15 ppm, pH 5 - 6.5)
before each test except the forced swim test and the tail
suspension test.
The open-field test was carried out to examine loco-
motor activity and anxiety-related behavior in a novel
environment. The open-field apparatus composed of
opaque white walls and a floor (50 × 50 × 50 cm) was
illuminated at an intensity of 40 lux. Each mouse was
placed in the center of the open-field arena, and then
locomotor (horizontal) activity was monitored for
20 min via a CCD camera positioned above the appara-
tus. The ambulatory distance and relative time spent in
the central zone were measured. To calculate relative
time spent in the center, the floor of the apparatus was
divided into 25 squares and time spent in the central
nine squares was measured. Fluoxetine did not signifi-
cantly affect vertical activity assessed by measuring the
number of infrared photobeam interruption. All records
were stored on a PC and analyzed using software based
on the public domain ImageJ (ImageJ OF; O’Hara and
Co., Ltd., Tokyo, Japan).
The light/dark transition test was carried out to assess
anxiety-related behavior. The apparatus for this test was
composed of a box (21 × 42 × 25 cm) divided into two
compartments of equal size. One compartment was
brightly illuminated at an intensity of 600 lux and a
CCD camera was equipped on the ceiling, whereas the
other was not illuminated (8 lux) and an infrared cam-
era was equipped on the ceiling. The partition dividing
the compartments had an opening (5 × 3 cm) with a
sliding door through which mice could move from one
compartment to the other. Single mice were put into
the dark compartment and the sliding door was automa-
tically opened after 5 s. The behavior of mice was moni-
tored for 10 min. The total number of transitions
between chambers, time spent in each side, the first
latency to enter the light side and the distance traveled
in each side were recorded automatically and analyzed
using software based on the public domain ImageJ (Ima-
geJ LD2, O’Hara & Co., Ltd., Tokyo, Japan). When mice
did not enter the light compartment, the latency was
considered 600 s.
The elevated plus-maze test was carried out to exam-
ine anxiety-related behavior. The apparatus consisted of
a central platform (5 × 5 cm), two opposed open arms
(25 × 5 cm) and two opposed closed arms of the same
size, but with 15-cm-high opaque walls. The edges of
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the open arms were raised 0.25 cm to avoid falls of
mice. The floor of each arm was made of white plastic.
The apparatus was elevated to a height of 50 cm above
the floor and illuminated at an intensity of 40 lux. At
the beginning of each test, one of the open arms was
blocked by a transparent obstacle and each mouse was
placed on the central platform, facing the blocked open
arm. After the mouse entered either of the closed arms,
the block was removed and the test was started. Activity
of mice was monitored for 10 min via a CCD camera
positioned above the apparatus. The time spent in each
arm, the number of entries into each arm and the
ambulatory distance were recorded and analyzed using
software based on the public domain ImageJ (ImageJ
EP, O’Hara & Co., Ltd., Tokyo, Japan).
The forced swim test was carried out to assess depres-
sion-related behavior. The apparatus consisted of a
transparent plastic cylinder (22 cm in height and 12 cm
in diameter) placed in a box (30.5 × 40 × 40 cm). The
cylinder was filled with water (25°C) up to a height of
10 cm and was illuminated from the bottom of the box.
Each mouse was placed into the cylinder and activity
was monitored for 15 min via a CCD camera mounted
on the top of the box. Immobile time except for first 2
min was measured. The cylinder was refilled with clean
water after each test. All records were stored on a PC
and analyzed using software based on the public domain
ImageJ (ImageJ PS4, O’Hara & Co., Ltd., Tokyo, Japan).
The tail suspension test was carried out to examine
depression-related behavior. The tip (1 cm) of mouse
tail was securely fastened with adhesive tape to a metal-
lic plate. The plate was hung from the ceiling of a test
box (30.5 × 40 × 40 cm). Immobile time was measured
for 6 min with a CCD camera mounted on the side of
the box. All records were stored on a PC and analyzed
using software based on the public domain ImageJ
(ImageJ PS4, O’Hara & Co., Ltd., Tokyo, Japan).
Electrophysiology
Mice were decapitated under deep halothane anesthesia
and both hippocampi were isolated. Transverse hippo-
campal slices (380 μm) were cut using a tissue slicer in
ice-cold sucrose-containing saline composed of (in
mM): sucrose 72, NaCl 80, KCl 2.5, NaH2PO4 1.0,
NaHCO3 26.2, glucose 20, CaCl2 0.5, MgCl2 7 (equili-
brated with 95% O2 /5% CO2). Slices were then incu-
bated for 30 min at 30°C and maintained in a
humidified interface holding chamber at room tempera-
ture (24 - 27°C) before recordings. Electrophysiological
recordings were made in a submersion-type chamber
maintained at 27.0 - 27.5°C and superfused at 2 ml/min
with saline composed of (in mM): NaCl 125, KCl 2.5,
NaH2PO4 1.0, NaHCO3 26.2, glucose 11, CaCl2 2.5,
MgCl2 1.3 (equilibrated with 95% O2 /5% CO2). Field
excitatory postsynaptic potentials (fEPSPs) arising from
the mossy fiber synapses were evoked by electrical sti-
mulation delivered to the dentate granule cell layer and
recorded from the stratum lucidum of CA3 using a
glass pipette filled with 2 M NaCl. The amplitude of
fEPSPs was measured on analysis as described [28]. A
criterion used to identify the mossy fiber input was
more than 85% block of fEPSP amplitude by an agonist
of group II metabotropic glutamate receptors, (2
S,2’R,3’R)-2-(2’,3’-dicarboxycyclopropyl)glycine (1 μM)
(Tocris Bioscience, Bristol, UK). Single electrical stimu-
lation was delivered at a frequency of 0.05 Hz for base-
line recordings and frequency facilitation was examined
at 1 Hz. All recordings were made using a Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA,
USA), filtered at 2 kHz and stored in a personal compu-
ter via an interface (digitized at 5 - 10 kHz).
Statistics
The number of data (n) represents the number of mice.
Since some data from drug-treated mice did not distri-
bute normally, nonparametric tests were used to evalu-
ate statistical significance. The two-tailed Mann-
Whitney test and Dunn’s multiple comparison test were
used to compare two groups and three groups or more,
respectively, with the significance level P < 0.05. All sta-
tistical tests were performed using GraphPad Prism ver-
sion 3.03 for Windows (GraphPad Software, San Diego,
CA, USA).
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